Dr. Naoto T. Ueno
Claim this profileM D Anderson Cancer Center
Expert in Breast Cancer
Studies Cancer
13 reported clinical trials
26 drugs studied
Area of expertise
1Breast Cancer
Global LeaderHER2
Stage IV
Stage III
2Cancer
HER2
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Naoto T. Ueno is currently running
DB-1305
for Solid Tumors
This trial is testing a new drug called DB-1305 to see if it is safe for patients with advanced solid tumors that are hard to treat. The study will begin with smaller amounts of the drug and increase them over time to find the safest and most effective dose.
Recruiting1 award Phase 1 & 24 criteria
Valemetostat + Trastuzumab Deruxtecan
for Breast Cancer
This trial is testing a new drug called valemetostat with an existing drug, trastuzumab deruxtecan, for patients with a specific type of breast cancer that doesn't respond well to usual treatments. The combination aims to stop cancer cell growth and deliver chemotherapy directly to the cancer cells.
Recruiting1 award Phase 113 criteria
More about Naoto T. Ueno
Clinical Trial Related7 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Naoto T. Ueno has experience with
- Paclitaxel
- Pembrolizumab
- Panitumumab
- Carboplatin
- Valemetostat
- Trastuzumab Deruxtecan
Breakdown of trials Naoto T. Ueno has run
Breast Cancer
Cancer
- Enzalutamide + Paclitaxel for Breast Cancer
- Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer
Swelling
Erythema
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Naoto T. Ueno specialize in?
Naoto T. Ueno focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 patients, or patients who are Stage IV.
Is Naoto T. Ueno currently recruiting for clinical trials?
Yes, Naoto T. Ueno is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Naoto T. Ueno has studied deeply?
Yes, Naoto T. Ueno has studied treatments such as Paclitaxel, Pembrolizumab, Panitumumab.
What is the best way to schedule an appointment with Naoto T. Ueno?
Apply for one of the trials that Naoto T. Ueno is conducting.
What is the office address of Naoto T. Ueno?
The office of Naoto T. Ueno is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.